SPY423.47-0.84 -0.20%
DIA343.14-1.98 -0.57%
IXIC14,109.28+39.86 0.28%

--Chardan Adjusts Price Target on Iovance Biotherapeutics to $54 From $52, Maintains Buy Rating

05/07/2021 09:12

01:11 PM EDT, 05/07/2021 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 28.98, Change: +0.37, Percent Change: +1.29